SleepRes
Murfreesboro, US · Founded 2022 · Delaware corporation
Find your way into SleepRes
Sign up to see every warm intro you have to SleepRes
- Paths you didn't know you had: your email and LinkedIn already hold routes to the SleepRes team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
SleepRes develops Kairos Positive Airway Pressure (KPAP), a pressure-delivery approach for treating sleep apnea, delivered through Kricket, an FDA-approved PAP device. The company serves sleep apnea patients and healthcare providers, aiming to improve therapy adherence compared to conventional CPAP.
Founders & leadership
SleepRes was founded in 2022 by Dr. William H. Noah.
DW

Dr. William H. NoahFounder
CS

Craig SalazarChief Financial OfficerCraig Salazar is Chief Financial Officer at SleepRes, where he oversees financial planning and capital allocation for the company's sleep apnea treatment platform. He has held finance leadership roles focused on forecasting, capital planning, and operational strategy in technically complex environments.
JL
John LipmanNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$2.6M disclosed across 2 of 4 rounds · 2024–2026
▶$450KraisedJul 2026 · 3 investors · Other Health CareRule 506(c)
▶$450KraisedJul 2026 · 3 investors · Other Health Care
Rule 506(c)Officers, directors & promoters on the filing
- William NoahExecutive Officer, Director
- John LipmanExecutive Officer, Director
- Craig SalazarExecutive Officer, Director
- Amount sold
- $450K
- Minimum investment
- $100K
- First sale
- Jul 2026
- Incorporated
- Corporation, Delaware, 2022
- Federal exemptions
- 06c
▶$6MofferedJun 2026 · Other Health CareRule 506(c)
▶$6MofferedJun 2026 · Other Health Care
Rule 506(c)Officers, directors & promoters on the filing
- William NoahExecutive Officer, Director
- Craig SalazarExecutive Officer, Director
- John LipmanExecutive Officer, Director
- Offering amount
- $6M
- Minimum investment
- $500K
- Incorporated
- Corporation, Delaware, 2022
- Federal exemptions
- 06c
▶Undisclosed amountofferedSep 2025 · Other Health CareRule 506(c)
▶Undisclosed amountofferedSep 2025 · Other Health Care
Rule 506(c)Officers, directors & promoters on the filing
- John LipmanExecutive Officer, Director
- Craig SalazarExecutive Officer, Director
- William NoahExecutive Officer, Director
- Minimum investment
- $100K
- Incorporated
- Corporation, Delaware, 2022
- Federal exemptions
- 06c
▶$2.2MraisedAug 2024 · 6 investors · Other Health CareRule 506(b)
▶$2.2MraisedAug 2024 · 6 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Craig SalazarExecutive Officer, Director
- William NoahExecutive Officer, Director
- Amount sold
- $2.2M
- Minimum investment
- $100K
- First sale
- Jul 2024
- Incorporated
- Corporation, Delaware, 2022
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- What does SleepRes do?
- SleepRes develops Kairos Positive Airway Pressure (KPAP), a pressure-delivery approach for treating sleep apnea, delivered through Kricket, an FDA-approved PAP device. The company serves sleep apnea patients and healthcare providers, aiming to improve therapy adherence compared to conventional CPAP.
- Who founded SleepRes?
- SleepRes was founded by Dr. William H. Noah in 2022.
- How much funding has SleepRes raised?
- SleepRes has disclosed $2.6M raised across 2 of its 4 known rounds.
- Where is SleepRes headquartered?
- SleepRes is headquartered in Murfreesboro, US.
